(S)-tert-butyl 6-hydroxy-1,4-oxazepane-4-carboxylate, 95.0%, 1g

3-(5-Fluoro-1H-indol-3-yl)propanoic acid, 96%, 5g

4,7,10,13,16,19,22,25,28-Nonaoxahentriacontanedioic acid, 1,31-bis(2,5-dioxo-1-pyrrolidinyl) ester, 97%, 25mg

3-Chloro-2-fluoro-6-iodobenzoic acid, 98%, 5g

7-(1-(Piperidin-4-yl)-1H-pyrazol-4-yl)-4-(p-tolyloxy)quinoline, 97%, 100mg

6-Bromo-2-ethyl-N,8-dimethylimidazo[1,2-a]pyridin-3-amine, 95%, 1g

H-Ala-Trp-OH>98.0%(HPLC)(T)250mg

1-(4-Chlorophenyl)-7-isopropoxy-6-methoxy-2-(4-nitrophenyl)-1,2-dihydroisoquinolin-3(4H)-one, 98%, 100mg

2-Bromo-5-chloroquinazoline, 98%, 100mg

2-methyl-1,2,3,4-tetrahydroquinoline-8-carboxylic acid, 95.0%, 1g

(S)-1-Methyl-pyrrolidin-3-ylamine, 96.0%, 250mg

(2E)-3-(2-ethoxyphenyl)-1-(4-ethylphenyl)prop-2-en-1-one, 95.0%, 10g

2-(Methoxycarbonyl)nicotinic acid, 97.0%, 25g